← Leaderboards
Paul Joseph Gaglio
Tulane University Of Louisiana
$75,559
Attributed
$75,559
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$75,559 · 5
By mechanism
P51$53,199 · 1
M01$22,360 · 4
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Juan J. L. Lertora$4,837,795
- Russell Barrett Van Dyke$24,377,705
- Srikanta Dash$6,178,827
- William McKinnon$49,515
- Newton E Hyslop$54,429
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical Trial Phase IHepatitis CHuman SubjectHuman Therapy EvaluationInterferon AlphaRibavirinImmunotherapyHepatitis C VirusDrug Screening /EvaluationMicroorganism Disease ChemotherapyLiver Disorder ChemotherapyCombination ChemotherapySerology /SerodiagnosisRelapse /Recurrence
Grant awards (9)
A PRIMATE MODEL FOR LIVER REGENERATION BY MARROW-DERIVED CELLS$53,199
P51 · FY2003 · RR
INTRON A/RIBAVIRIN FOR TREATMENT WITH INTERFERON RELAPSED CHRONIC HEPATITIS C$0
M01 · FY2001 · RR
INTRON A &RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C NOT PREVIOUSLY TREATED$0
M01 · FY2001 · RR
DAILY INDUCTION THERAPY WITH INFERGEN FOR HCV$0
M01 · FY2001 · RR
DOSAGE COMPARISON OF INFERGEN FOR HCV$0
M01 · FY2001 · RR
INTRON A &RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C NOT PREVIOUSLY TREATED$11,180
M01 · FY2000 · RR
INTRON A/RIBAVIRIN FOR TREATMENT WITH INTERFERON RELAPSED CHRONIC HEPATITIS C$11,180
M01 · FY2000 · RR
DAILY INDUCTION THERAPY WITH INFERGEN FOR HCV$0
M01 · FY2000 · RR
DOSAGE COMPARISON OF INFERGEN FOR HCV$0
M01 · FY2000 · RR